Recent studies have shown that CXCL10 expression is increased in the serum and/or tissues of patients with various autoimmune diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus, desiccation syndrome, systemic sclerosis, and idiopathic inflammatory myopathies). Here, CXCL10 is linked to rheumatoid arthritis.